Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachael Curley

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Respiratory Medicine|August 8, 2020
A comparison of the CFHH criteria against the Leeds criteria in determining the Pseudomonas aeruginosa status among adults with cystic fibrosisZhe Hui Hoo, Lydia Hitchcock, Rachael Curley, et al.
Patient Preference and Adherence|April 11, 2017
An empirical method to cluster objective nebulizer adherence data among adults with cystic fibrosisZhe H Hoo, Michael J Campbell, Rachael Curley, et al.
F1000Research|March 24, 2018
Case Report: Dual nebulised antibiotics among adults with cystic fibrosis and chronic <i>Pseudomonas</i> infectionNina Mann, Shirley Murray, Zhe Hui Hoo, et al.
F1000Research|November 27, 2018
Using different methods to process forced expiratory volume in one second (FEV <sub>1</sub>) data can impact on the interpretation of FEV <sub>1</sub> as an outcome measure to understand the performance of an adult cystic fibrosis centre: A retrospective chart reviewZhe Hui Hoo, Muhaned S A El-Gheryani, Rachael Curley, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 19, 2022
Regarding the articles on home spirometryRachael Curley, Michael J Campbell, Stephen J Walters, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 28, 2017
Do cystic fibrosis centres with the lowest FEV<sub>1</sub> still use the least amount of intravenous antibiotics? A registry-based comparison of intravenous antibiotic use among adult CF centres in the UKZhe Hui Hoo, Michael J Campbell, Rachael Curley, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 4, 2019
Exploring the implications of different approaches to estimate centre-level adherence using objective adherence data in an adult cystic fibrosis centre - a retrospective observational studyZhe Hui Hoo, Rachael Curley, Stephen J Walters, et al.
Respirology (Carlton, Vic.)|September 15, 2017
Rescue therapy within the UK Cystic Fibrosis Registry: An exploration of predictors of intravenous antibiotic use amongst adults with CFZhe Hui Hoo, Martin J Wildman, Rachael Curley, et al.
Journal of Evaluation in Clinical Practice|June 15, 2018
The importance of data issues when comparing cystic fibrosis registry outcomes between countries: Are annual review FEV<sub>1</sub> in the UK only collected when subjects are well?Zhe Hui Hoo, Rachael Curley, Michael J Campbell, et al.
Patient Preference and Adherence|September 9, 2015
Promoting adherence to nebulized therapy in cystic fibrosis: poster development and a qualitative exploration of adherenceStephen Jones, Nathan Babiker, Emma Gardner, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Respiratory Medicine|August 8, 2020
A comparison of the CFHH criteria against the Leeds criteria in determining the Pseudomonas aeruginosa status among adults with cystic fibrosisZhe Hui Hoo, Lydia Hitchcock, Rachael Curley, et al.
Patient Preference and Adherence|April 11, 2017
An empirical method to cluster objective nebulizer adherence data among adults with cystic fibrosisZhe H Hoo, Michael J Campbell, Rachael Curley, et al.
F1000Research|March 24, 2018
Case Report: Dual nebulised antibiotics among adults with cystic fibrosis and chronic <i>Pseudomonas</i> infectionNina Mann, Shirley Murray, Zhe Hui Hoo, et al.
F1000Research|November 27, 2018
Using different methods to process forced expiratory volume in one second (FEV <sub>1</sub>) data can impact on the interpretation of FEV <sub>1</sub> as an outcome measure to understand the performance of an adult cystic fibrosis centre: A retrospective chart reviewZhe Hui Hoo, Muhaned S A El-Gheryani, Rachael Curley, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 19, 2022
Regarding the articles on home spirometryRachael Curley, Michael J Campbell, Stephen J Walters, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 28, 2017
Do cystic fibrosis centres with the lowest FEV<sub>1</sub> still use the least amount of intravenous antibiotics? A registry-based comparison of intravenous antibiotic use among adult CF centres in the UKZhe Hui Hoo, Michael J Campbell, Rachael Curley, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 4, 2019
Exploring the implications of different approaches to estimate centre-level adherence using objective adherence data in an adult cystic fibrosis centre - a retrospective observational studyZhe Hui Hoo, Rachael Curley, Stephen J Walters, et al.
Respirology (Carlton, Vic.)|September 15, 2017
Rescue therapy within the UK Cystic Fibrosis Registry: An exploration of predictors of intravenous antibiotic use amongst adults with CFZhe Hui Hoo, Martin J Wildman, Rachael Curley, et al.
Journal of Evaluation in Clinical Practice|June 15, 2018
The importance of data issues when comparing cystic fibrosis registry outcomes between countries: Are annual review FEV<sub>1</sub> in the UK only collected when subjects are well?Zhe Hui Hoo, Rachael Curley, Michael J Campbell, et al.
Patient Preference and Adherence|September 9, 2015
Promoting adherence to nebulized therapy in cystic fibrosis: poster development and a qualitative exploration of adherenceStephen Jones, Nathan Babiker, Emma Gardner, et al.
Pageof 2